What Researchers Did
The authors wrote a review of how aging cells in the brain, called senescent cells, may relate to brain aging and memory and thinking decline.
What They Found
This narrative review describes cellular senescence as a biological hallmark of aging that plays a key role in the development of neurodegenerative diseases. The abstract reports no sample size, numbers or percentages. It says clinical trials are underway to test treatments that target senescent cells (senotherapies) in these diseases. It states that the effect of senescence on brain aging and cognitive decline without neurodegeneration remains uncertain. It also says that cancer survivors, traumatic brain injury survivors, obese individuals, people with obstructive sleep apnea and people with chronic kidney disease can have cognitive decline earlier than expected, which suggests they may have accelerated senescence in the brain. The authors discuss caveats of mainstream senotherapies and present emerging evidence of hyperbaric oxygen therapy and immune-directed therapies as viable ways to reduce the burden of senescent cells.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This is a review rather than a trial, the abstract reports no data from patients treated with hyperbaric oxygen, and it says the role of senescence in cognitive decline without neurodegeneration is still uncertain.